Susquehanna Portfolio Strategies’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-7,463
Closed -$432K 337
2024
Q3
$432K Hold
7,463
0.03% 260
2024
Q2
$303K Hold
7,463
0.01% 422
2024
Q1
$313K Sell
7,463
-2,327
-24% -$90.8K 0.01% 660
2023
Q4
$375K Buy
+9,790
New +$326K 0.01% 818

Other funds holding ASTH

Susquehanna Portfolio Strategies's ASTH Position: Q4 2024 in Review

Susquehanna Portfolio Strategies sold out of Astrana Health (ASTH) in Q4 2024, closing a stake of 7,463 shares — an estimated $432K sold.

Susquehanna Portfolio Strategies first reported a position in ASTH in Q4 2023 and held it in 4 quarters. The position peaked at $432K in Q3 2024. 179 funds tracked by Wall St. Rank hold ASTH as of Q4 2024.

  • Susquehanna Portfolio Strategies reported no remaining Astrana Health position as of Q4 2024 after selling out during the quarter.
  • Susquehanna Portfolio Strategies sold 7,463 Astrana Health shares in Q4 2024, an estimated $432K.
  • Susquehanna Portfolio Strategies first reported a position in Astrana Health in Q4 2023 and held it in 4 quarters.
  • Susquehanna Portfolio Strategies's Astrana Health position peaked at $432K in Q3 2024.
  • 179 funds tracked by Wall St. Rank held Astrana Health as of Q4 2024.

Based on Susquehanna Portfolio Strategies's 13F filing for Q4 2024, filed 14 Feb 2025.